VK, R., SB, D., & MI, E. (2022). Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease. Journal of medical economics, 25(1), 347. https://doi.org/10.1080/13696998.2022.2026702
Chicago Style (17th ed.) CitationVK, Rustgi, Duff SB, and Elsaid MI. "Cost-effectiveness and Potential Value of Pharmaceutical Treatment of Nonalcoholic Fatty Liver Disease." Journal of Medical Economics 25, no. 1 (2022): 347. https://doi.org/10.1080/13696998.2022.2026702.
MLA (9th ed.) CitationVK, Rustgi, et al. "Cost-effectiveness and Potential Value of Pharmaceutical Treatment of Nonalcoholic Fatty Liver Disease." Journal of Medical Economics, vol. 25, no. 1, 2022, p. 347, https://doi.org/10.1080/13696998.2022.2026702.